FO

Frank Osterkamp

SG Shire Orphan Therapies Gmbh: 8 patents #3 of 28Top 15%
BI Baxalta Incorporated: 6 patents #23 of 230Top 10%
BI Baxter International: 3 patents #645 of 2,334Top 30%
BS Baxter Healthcare Sa: 3 patents #329 of 1,132Top 30%
3G 3B Pharmaceuticals Gmbh: 3 patents #1 of 14Top 8%
AR Alcon Research: 1 patents #145 of 267Top 55%
TL Takeda Pharmaceutical Company Limited: 1 patents #859 of 1,531Top 60%
Overall (All Time): #179,773 of 4,157,543Top 5%
23
Patents All Time

Issued Patents All Time

Showing 1–23 of 23 patents

Patent #TitleCo-InventorsDate
12427210 Compounds comprising a fibroblast activation protein ligand and use thereof Dirk Zboralski, Eberhard Schneider, Christian HAASE, Matthias Paschke, Aileen HÖHNE +4 more 2025-09-30
11793855 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich +2 more 2023-10-24
10961199 Neurotensin receptor ligands Christiane SMERLING, Ulrich Reineke, Christian HAASE, Jan UNGEWIß 2021-03-30
10799605 Conjugate comprising a neurotensin receptor ligand and use thereof Christian HAASE, Ulrich Reineke, Christiane SMERLING, Matthias Paschke, Jan UNGEWIß 2020-10-13
10800816 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Friedrich Scheiflinger, Thomas Polakowski, Ulrich Reineke 2020-10-13
10201586 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich +2 more 2019-02-12
10196423 NPR-B agonists Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer, Ulrich Reineke +5 more 2019-02-05
10124033 Peptides and methods of use Michael Dockal, Thomas Polakowski, Rudolf Hartmann, Matthias Paschke, Bettina Hartlieb +1 more 2018-11-13
9982016 NPR-B agonists Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer, Ulrich Reineke +5 more 2018-05-29
9873720 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Friedrich Scheiflinger, Thomas Polakowski, Ulrich Reineke 2018-01-23
9745344 NPR-B agonists Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer, Ulrich Reineke +5 more 2017-08-29
9556230 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich +2 more 2017-01-31
9458198 Cyclic peptide-based NPR-B agonists Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer, Ulrich Reineke +5 more 2016-10-04
9447147 Peptides and methods of use Michael Dockal, Thomas Polakowski, Rudolf Hartmann, Matthias Paschke, Bettina Hartlieb +1 more 2016-09-20
9169293 NPR-B agonists Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer, Ulrich Reineke +5 more 2015-10-27
9018167 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich +2 more 2015-04-28
8962563 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Friedrich Scheiflinger, Thomas Polakowski, Ulrich Reineke 2015-02-24
8927534 Compounds for the inhibition of integrins and use thereof Gunther Zischinsky, Roland Stragies, Dirk Scharn, Gerd Hummel, Holger Kalkhof +4 more 2015-01-06
8546523 NPR-B agonists Heiko Hawlisch, Gerd Hummel, Tobias Knaute, Ulf Reimer, Ulrich Reineke +5 more 2013-10-01
8501787 Compounds for the inhibition of angiogenesis and use thereof Grit Zahn, Roland Stragies, Gunther Zischinsky, Jochen Knolle, Gerd Hummel +2 more 2013-08-06
8450275 TFPI inhibitors and methods of use Michael Dockal, Rudolf Hartmann, Markus Fries, Friedrich Scheiflinger, Hartmut Ehrlich +2 more 2013-05-28
8309735 Heterocyclic compounds for the inhibition of integrins and use thereof Gunther Zischinsky, Roland Stragies, Dirk Scharn, Gerd Hummel, Holger Kalkhof +4 more 2012-11-13
8029979 Method for determining the substrate specificity of an enzyme Jens Schneider-Mergener, Mike Schutkowski, Ulf Reimer, Liying Dong, Soren Panse +3 more 2011-10-04